UFP Technologies, Inc. Lease, Cost
UFP Technologies, Inc. (UFPT) reported Lease, Cost of $3.51 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-06
- UFP Technologies, Inc. lease, cost for the quarter ending 2026-06-30 was $1.83M, a 18.08% increase year-over-year.
- UFP Technologies, Inc. lease, cost for the quarter ending 2026-03-31 was $1.68M, a 35.27% increase year-over-year.
- UFP Technologies, Inc. lease, cost for the quarter ending 2025-12-31 was $1.55M, a 25.65% increase year-over-year.
- UFP Technologies, Inc. lease, cost for the quarter ending 2025-09-30 was $1.63M, a 33.66% increase year-over-year.
- UFP Technologies, Inc. lease, cost for fiscal 2025 was $5.97M, a 33.76% increase from fiscal 2024.
- UFP Technologies, Inc. lease, cost for fiscal 2024 was $4.46M, a 24.33% increase from fiscal 2023.
- UFP Technologies, Inc. lease, cost for fiscal 2023 was $3.59M, a 17.76% increase from fiscal 2022.
- UFP Technologies, Inc. lease, cost for fiscal 2022 was $3.05M, a 90.56% increase from fiscal 2021.
| Period end | Lease, Cost 3 month | Lease, Cost 6 month | Lease, Cost 9 month | Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $3.51M 10-Q · filed 2026-08-06 | $5.06M derived: sum of 3 quarters · filed 2026-08-06 | $6.68M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $1.68M 10-Q · filed 2026-05-08 | $3.23M derived: sum of 2 quarters · filed 2026-05-08 | $4.86M derived: sum of 3 quarters · filed 2026-05-08 | $6.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.18M derived: sum of 2 quarters · filed 2026-02-27 | $4.72M derived: sum of 3 quarters · filed 2026-08-06 | $5.97M 10-K · filed 2026-02-27 |
| 2025-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.18M derived: sum of 2 quarters · filed 2026-08-06 | $4.42M 10-Q · filed 2025-11-07 | $5.65M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.79M 10-Q · filed 2026-08-06 | $4.02M derived: sum of 3 quarters · filed 2026-08-06 | $5.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.24M 10-Q · filed 2026-05-08 | $2.47M derived: sum of 2 quarters · filed 2026-05-08 | $3.69M derived: sum of 3 quarters · filed 2026-05-08 | $4.71M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.45M derived: sum of 2 quarters · filed 2026-02-27 | $3.46M derived: sum of 3 quarters · filed 2026-02-27 | $4.46M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $2.23M derived: sum of 2 quarters · filed 2025-11-07 | $3.23M 10-Q · filed 2025-11-07 | $4.19M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $2.01M 10-Q · filed 2025-08-11 | $2.97M derived: sum of 3 quarters · filed 2026-02-27 | $3.91M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $996.00K 10-Q · filed 2025-05-12 | $1.95M derived: sum of 2 quarters · filed 2026-02-27 | $2.90M derived: sum of 3 quarters · filed 2026-02-27 | $3.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $958.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.90M derived: sum of 2 quarters · filed 2026-02-27 | $2.77M derived: sum of 3 quarters · filed 2026-02-27 | $3.59M 10-K · filed 2026-02-27 |
| 2023-09-30 | $945.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.81M derived: sum of 2 quarters · filed 2024-11-12 | $2.63M 10-Q · filed 2024-11-12 | $3.39M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $868.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.69M 10-Q · filed 2024-08-09 | $2.44M derived: sum of 3 quarters · filed 2024-08-09 | $3.20M derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $817.00K 10-Q · filed 2024-05-10 | $1.58M derived: sum of 2 quarters · filed 2024-05-10 | $2.33M derived: sum of 3 quarters · filed 2024-05-10 | $3.11M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $759.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $1.51M derived: sum of 2 quarters · filed 2024-02-29 | $2.29M derived: sum of 3 quarters · filed 2024-02-29 | $3.05M 10-K · filed 2024-02-29 |
| 2022-09-30 | $755.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.53M derived: sum of 2 quarters · filed 2023-11-09 | $2.29M 10-Q · filed 2023-11-09 | $2.78M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $778.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.53M 10-Q · filed 2023-08-09 | $2.02M derived: sum of 3 quarters · filed 2023-08-09 | $2.39M derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | $755.00K 10-Q · filed 2023-05-10 | $1.25M derived: sum of 2 quarters · filed 2023-05-10 | $1.61M derived: sum of 3 quarters · filed 2023-05-10 | $1.98M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $490.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-16 | $859.00K derived: sum of 2 quarters · filed 2023-03-16 | $1.23M derived: sum of 3 quarters · filed 2023-03-16 | $1.60M 10-K · filed 2023-03-16 |
| 2021-09-30 | $369.00K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14 | $737.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.11M 10-Q/A · filed 2022-11-14 | $1.47M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $368.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $740.00K 10-Q · filed 2022-08-09 | $1.10M derived: sum of 3 quarters · filed 2022-08-09 | $1.47M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $372.00K 10-Q · filed 2022-05-10 | $734.00K derived: sum of 2 quarters · filed 2022-05-10 | $1.10M derived: sum of 3 quarters · filed 2022-05-10 | $1.47M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $362.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $728.00K derived: sum of 2 quarters · filed 2022-03-14 | $1.09M derived: sum of 3 quarters · filed 2022-03-14 | $1.46M 10-K · filed 2022-03-14 |
| 2020-09-30 | $366.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $731.00K derived: sum of 2 quarters · filed 2021-11-05 | $1.10M 10-Q · filed 2021-11-05 | $1.46M derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $365.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $734.00K 10-Q · filed 2021-08-06 | $1.10M derived: sum of 3 quarters · filed 2021-08-06 | $1.47M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $369.00K 10-Q · filed 2021-05-07 | $732.00K derived: sum of 2 quarters · filed 2021-05-07 | $1.10M derived: sum of 3 quarters · filed 2021-05-07 | $1.47M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $363.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $731.00K derived: sum of 2 quarters · filed 2021-03-12 | $1.10M derived: sum of 3 quarters · filed 2021-03-12 | $1.47M 10-K · filed 2021-03-12 |
| 2019-09-30 | $368.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $735.00K derived: sum of 2 quarters · filed 2020-11-06 | $1.10M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $737.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $370.00K 10-Q · filed 2020-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |